MedTrace Logo

Pharmacodynamic Drug Interaction Between Cilostazol and Statins

NCT01870466 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2015-05-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate pharmacodynamic drug interaction between cilostazol and statins (simvastatin as a CYP3A substrate and rosuvastatin as a non-CYP3A substrate) in healthy male subjects.

Conditions

  • Healthy

Interventions

DRUG

Cilostazol

cilostazol bid for 7 days

DRUG

Simvastatin

simvastatin qd for 7 days

DRUG

Rosuvastatin

rosuvastatin qd for 7 days

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Jae-Wook Ko, MD, PhD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01870466 on ClinicalTrials.gov